Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease

Archives of Virology

Volumn 143, Issue 5, 1998, Pages 915-930

  Sheppard, M ^a,b   Werner, W ^a,b   Tsatas, E ^a   McCoy, R ^a,c   Prowse, S ^a   Johnson, M ^a  

^a CSIRO   (Australia)

^b PFIZER INC   (United States)

^c Australian Inst of Mucosal Immunol   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BURSAL DISEASE; EXPRESSION VECTOR; FOWL ADENOVIRUS; GENE INSERTION; IMMUNIZATION; PROMOTER REGION; RECOMBINANT GENE; SEROTYPE; VIRUS GENOME;

ANIMALS; ANTIBODIES, VIRAL; AVIADENOVIRUS; BIRNAVIRIDAE INFECTIONS; CHICKENS; DNA, VIRAL; GENES, VIRAL; GENETIC VECTORS; INFECTIOUS BURSAL DISEASE VIRUS; MOLECULAR SEQUENCE DATA; POULTRY DISEASES; RECOMBINATION, GENETIC; RESTRICTION MAPPING; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

ADENOVIRIDAE; ANIMALIA; AVES; GALLIFORMES; GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS;

EID: 0031807246     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050342     Document Type: Article

References (53)

1. Arnberg N, Mei Y-F, Wadell G (1997) Fiber genes of adenoviruses with tropism for the eye and the genital tract. Virology 227: 239-244
2. Azad AA, Barrett SA, Fahey KJ (1985) The characterisation and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology 143: 35-44
3. Azad AA, Jagadish MN, Brown MM, Hudson PJ (1987) Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 161: 145-152
4. Azad AA, McKern NM, Macreadie IG, Failla P, Heine H, Chapman A, Ward CW, Fahey KJ (1991) Physiochemieal and immunological characterization of recombinant host-protective antigen VP2 of infectious bursal disease virus. Vaccine 9: 715-722
5. Bayliss CD, Spies U, Shaw K, Peters RW, Pagageorgiou A, Müller H, Boursnell MEG (1990) A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region of VP2. J Gen Virol 71: 1303-1312
6. Bayliss CD, Peters RW, Cook JKA, Reece RL, Howes K, Binns MM, Boursnell MEG (1991) A recombinant fowlpox virus that expressed the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch Virol 120: 193-205
7. Becht H, Müller H, Müller HK (1988) Comparative studies on the structural and antigenic properties of two serotypes of infectious bursal disease. J Gen Virol 69: 631-640
8. Brett AJ, Prevec L, Graham FL (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67: 5911-5921
9. Callebaut P, Enjunanes L, Pensaert M (1996) An adenovirus recombinant expressing the spike glycoprotein of porcine respiratory coronavirus is immunogenic in swine. J Gen Virol 77: 309-313
10. Charlton KM, Artois M, Prevec L, Campbell JB, Casey GA, Wandeler AI, Armstrong J (1992) Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch Virol 123: 169-179
11. Chiocca S, Kurzbauer R, Schaffner G, Baker A, Mautner V, Cotten M (1996) The complete DNA sequence and genomic organization of the avian adenovirus CELO. J Virol 70: 2939-2949
12. Darteil R, Bublot M, Laplace E, Bouquet J-F, Audonnet J-C, Riviere M (1995) Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV challenge in chickens. Virology 211: 481-490
13. Dobos P, Hill PJ, Hallett R, Keils DTC, Becht H, Teninges D (1979) Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32: 593-605
14. Erny KM, Barr DA, Fahey KJ (1991) Molecular characterization of highly virulent fowl adenoviruses associated with outbreaks of inclusion body hepatitis. Avian Pathol 20: 597-606
15. Erny KM, Pallister JA, Sheppard M (1995) Immunological and molecular comparison of fowl adenovirus serotypes 4 and 10. Arch Virol 140: 491-501
16. Erny KM, Sheppard M, Fahey KJ (1996) Immunopathogenesis and physical maps of fowl adenovirus serotype 9. Res Vet Sci 61: 174-175
17. Fahey KJ, Crooks JK, Fraser RA (1987) Assessment by ELISA of passively acquired protection against infectious bursal disease virus in chickens. Aust Vet J 64: 203-207
18. Fahey KJ, Erny K, Crooks J (1989) A conformational immunogen on VP2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70: 1473-1481
19. Fahey KJ, Chapman AJ, MaCreadie IG, Vaughan PR, McKern NM, Skicko JI, Ward CW, Azad AA (1991a) A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease. Avian Pathol 20: 447-460
20. Fahey KJ, McWaters P, Brown MA, Erny K, Murphy VJ, Hewish DR (1991b) Virusneutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickents. Avian Dis 35: 365-373
21. Fahey KJ, McWaters P, Brown P, Erny K, Murphy VJ, Hewish DR (1991c) Virus neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens. Avian Dis 35: 365-373
22. Gallichan WS, Johnson DC, Graham FL, Rosenthal KL (1993) Mucosal immunity and protection after intranassal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J Infect Dis 168: 622-629
23. Gallichan WS, Rosenthal KL (1995) Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13: 1589-1595
24. Gonin P, Fournier A, Oualikene W, Moraillon A, Eloit M (1995) Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus. Vet Microbiol 45: 393-401
25. Heine H-G, Haritou M, Failla P, Fahey K, Azad A (1991) Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J Gen Virol 72: 1835-1843
26. Heine H-G, Boyle DB (1993) Infectious bursal disease structural protein VP2 expressed by a fowlpox virus rcombinant confers protection against disease in chickens. Arch Virol 131: 277-292
27. Hirai K, Calnek BW (1975) In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken lymphocytes. Infect Immun 25: 964-970
28. Hong SS, Karayan L, Curiel DT, Boulanger PA (1997) Adenovirus type 5 fiber binds to MHC class I alpha 2 domain at the surface of human epithelial and B lymphoblastoid cell. EMBO J 16: 2294-2306
29. Hsu KL, Lubeck MD, Davis AR, Bhat RA, Selling BH, Bhat BM, Mizutani S, Murphy BR, Collins PL, Chanock RM, Hung PP (1992) Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adevnovirus types 4,5, and 7 vectors in dogs and a chimpanzee. J Infect Dis 166: 769-775
30. Hudson PJ, McKern, NM, Power BE, Azad AA (1986) Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Res 14: 5001-5012
31. Jagadish MN, Staton, VJ, Hudson PJ, Azad AA (1988) Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide. J Virol 62: 1084-1087
32. Johnson DC, Ghosh-Choudhury G, Smiley JR, Fallis L, Graham FL (1988) Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164: 1-14
33. Kalicharran KK, Springthorpe VS, Sattar SA (1992) Studies on stability of a human adenovirus-rabies recombinant vaccine. Can J Vet Res 56: 28-33
34. Kibenge FSB, Jackwood DJ, Mercado CC (1990) Nucleotide sequence analysis of genome segment A of infectious bursal disease virus. J Gen Virol 71: 569-577
35. Lubeck MD, Natuk RJ, Chengalvala M, Chanda PK, Murthy KK, Murthy S, Mizutani S, Lee S, Wade MS, Bhat BM, Bhat R, Dheer SK, Eichberg JW, Davis AR, Hung PP (1994) Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. Aids Res Hum Retroviruses 10: 1443-1449
36. Lucio B, Hitchner SB (1979) Infectious bursal disease emulsified vaccine: effect upon neutralizing antibody levels in the dam and subsequent protection of the progeny. Avian Dis 23: 466-478
37. Lutze-Wallace C, Wandeler A, Prevec L, Sidhu M, Sapp T, Armstrong J (1995) Characterization of human adenovirus 5: rabies glycoprotein recombinant vaccine reisolated from orally vaccinated skunks. Biologicals 23: 271-277
38. McDermott MR, Graham FL, Hanke T, Johnson DC (1989) Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169: 244-247
39. Mittal SK, Prevec L, Graham FL, Babiuk L (1995) Development of a bovine adenovirus type 3 base expression vector. J Gen Virol 76: 93-102
40. Morin JE, Lubeck MD, Barton JE, Conely AJ, Davis AR, Hung PP (1987) Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc Natl Acad Sci USA 84: 4624-4630
41. Natuk RJ, Chanda PK, Lubeck MD, Davis AR, Wilhelm J, Hjorth R, Wade MS, Bhat BM, Mizutani S, Lee S, Eichberg J, Gallo RC, Hung PP, Robert-Guroff M (1992) Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titred HIV-neutralizing antibodies in the dog model. Proc Natl Acad Sci USA 89: 7777-7781
42. Okoye JOA (1984) Infectious bursal disease of chickens. Vet Bull 54: 425-436
43. Pallister J, Wright PJ, Sheppard M (1996) A single gene encoding the liber is responsible for variations in virulence in the fowl adenoviruses. J Virol 70: 5115-5122
44. Ragot T, Eloit M, Perricaudet M (1991) Recombinant ElA-defective adenoviruses expressing pseudorabies and Epstein-Barr virus glycoproteins induce immunological responses as live vaccines in rabbits and mice. Hum Gene Transfer 219: 249-260
45. Ragot T, Finerty S, Watkins PE, Perricaudet M, Morgan AJ (1993) Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J Gen Virol 74: 501-507
46. Rosenberger JK, Cloud S (1985) Isolation and characterization of variant infectious bursal disease viruses. Abstracts 123rd American Veterinary Medical Association, p 357
47. Sheppard M, Werner W, McCoy RJ, Johnson MA (1998) The major late promoter and bipartite leader sequence of fowl adenovirus. Arch Virol 143: 537-548
48. Sheppard M, Werner W, Johnson MA (1998) DNA sequence of the fowl adenovirus serotype 10 short fiber gene. DNA Seq (in press)
49. Snyder DB, Lana DP, Savage PK, Yancey FS, Mengel SA, Marquardt WW (1988) Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates. Avian Dis 32: 535-539
50. Snyder DB, Vakharia VN, Savage PK (1992) Naturally occurring neutralizing monoclonal escape variants define the epidemiology of infectious bursal virus in the United States. Arch Virol 127: 89-101
51. Van den Berg TP, Gonze M, Meulemans G (1991) Acute infectious bursal disease in poultry: Isolation and characterization of a highly virulent strain. Avian Pathol 20: 133-143
52. Whitfill CE, Haddad EE, Ricks CA, Skeeles JK, Newberry LA, Beasley JN, Andrews PD, Thoma JA, Wakenell PS (1995) Determination of optimum formulation of a novel infectious bursal disease virus (IBDV) vaccine constructed by mixing bursal disease antibody with IBDV. Avian Dis 39: 687-699
53. Wyeth PJ, Chettle N (1982) Comparison of the efficacy of four inactivated infectious bursal disease emulsion vaccines. Vet Rec 110: 359-361